SELOUS GAME RESERVE: A PERFECT TANZANIA SAFARI

Selous National Park, Tanzania is one of the biggest confined wildlife areas of its kind in the entire Africa. A UNESO World Heritage Site – Selous National Park covers the area as big as a size of Belgium. Most of the Selous safari camps are located at or along the banks of Rufiji River that flows here. You can find beautiful focal safari camps along Rufiji River fed by local lakes and lagoons. A big amount of travelers get attracted by the game safaris at Selous Game Reserve as the sheer joy of watching wild animals pass you is worth having.

Travelers have options of choosing a way to experience these wildlife creatures in various ways, three common ways are game drives, walking safaris and boat safaris. All of these are certainly fun and extremely enjoyable. Certainly game drives are the popular choices among tourists visiting this game reserve but walking and boat safaris are also extremely fun and are certainly loved by people. You have to have a very experienced guide while on an open safari that can guide and make the most of your selous safari by pointing animals that you generally don’t notice and by protecting you against any threat. These guides are best guiding you with the names and history of different birds and animals, which you may come across for the first time in life.

As this is a game reserve and so you are certain to get encountered by the ‘Big Five’ – Lion, leopard, rhino, elephant and buffalo being attraction of game safaris. Selous does not have 4 seasons like other parts of the world, you can refer to the seasons as dry or wet here. You can easily spot the birds, game and the bigger predators as there is less foliage and most water holes dry out in the dry season. The game viewing is at its best during the dry season that generally lasts from June up till November. Rest of the year it is a wet season here and so game safaris are not as good; however, the early parts of wet season, which is during December to February are also good for game safaris but can feel a bit humid.

If you are a sheer bird lover, January to May is the best time to watch these; however the rains can be hurdle and most lodges and camps are closed during March to May. Selous game reserve is also popular for having world’s third largest African Wild Dog population. The wild dogs also known as Painted Dogs are social animal but are endangered and hunt in a heap. The river banks at Selous attract large masses of birds and the attractive fish eagle soaring high in the sky, which is certainly a treat to watch. You can also expect to see a lot of wading birds such as heron, storks. The water also contains some crocodiles and perilous hippo that can be seen occasionally bobbing their heads out of the water.

You need to spend at least 3 nights to make sure you make out the most of Selous Game reserve and then move to other nearly attractions such as Mikumi safari, which is also a great treat to visit. Click here to get more information on Tanzania Safari.

Respiratory Syncytial Virus Diagnostics Market Opportunity Analysis, 2018 – 2026

Respiratory Syncytial Virus (RSV) is responsible for many chronic conditions such as pneumonia, bronchitis, asthma, and respiratory disease. It primarily affects neonates, infants and adults and is responsible for outpatient visits, hospitalization and death in some cases. Therefore, diagnosis of RSV- associated diseases is crucial to avoid further medical severity. Symptoms of RSV presence include, rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia. Molecular diagnostic is most widely used techniques for diagnosing RSV.

Click To Continue Reading on Respiratory Syncytial Virus Diagnostics Market

According to a report by the Lancet, 2017, around 33·1 million episodes of RSV induced acute lower respiratory infections that resulted in around 3·2 million hospitalizations and around 59,600 in-hospital deaths in children younger than 5 years of age, worldwide, in 2015. Moreover, the report stated that the overall RSV- acute lower respiratory infections- related mortality was around 118200 in 2015.

Furthermore, high prevalence of several chronic conditions such as pneumonia and other respiratory tract infections due to RSV is a major factor contributing to growth of the market over the forecast period. For instance, according to a report by World Health Organization (WHO), May 2018, chronic obstructive pulmonary disease (COPD) and lower respiratory tract infection are amongst top five chronic diseases with highest mortality rate, worldwide. The report stated that around 3 million each deaths were registered due to COPD and lower respiratory tract infection in 2016, worldwide.

On the basis of Geography, respiratory syncytial virus diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the respiratory syncytial virus diagnostics market over the forecast period.

According to study published in journal American Family Physician in 2017, around 2% to 3% of infants, younger than 12 months are hospitalized with an RSV infection, annually, in the U.S. As per same source, Around 57,500 hospitalizations and 2.1 million outpatient visits are associated with RSV infections in children younger than five years, annually, in the U.S. It can be concluded from epidemiological data that the U.S. has high potential for respiratory syncytial virus diagnostics market. Presence of key players and their products in North America would be another important driver for the market growth.

Asia Pacific and Latin America would witness highest CAGR in respiratory syncytial virus diagnostics market. According to study published in the Lancet in September 2017, lower middle income countries witnessed around 43,600 deaths due to RSV-ALRI whereas upper middle income countries witnessed around 17900 deaths, in 2015. Furthermore, children in this region often do not receive adequate vaccination, which leads to frequent infection incidences from variety of diseases including RSV. According to World Health Organization (WHO) 2018, worldwide, around 86% of infants are vaccinated against 26 diseases. However, around 19.5 million children remain unvaccinated that leads to around 2-3 million deaths, annually, of which around 90% belong to low and middle income countries.

WHO is running the pilot projects of vaccination in countries of developing regions such Latin America, Africa, and Asia Pacific to achieve100% detection of the RSV infections amongst infants, neonates and children under five years of age.This is expected to reduce the mortality rate and hospitalization from RSV associated acute lower respiratory infections (ALRI). It would also establish RSV diagnostic centers over the forecast period in these regions.

Angioplasty Balloons Market Opportunity Analysis, 2018-2026

Angioplasty balloon is a medical device that is used for surgical widening or unblocking of a blood vessel, especially a coronary artery. A noticeable increase in health conditions have been is observed due to some factors that cause heart related diseases such as obesity, poor diet, and extra cholesterol. .Coronary artery disease is a life threatening disease which occurs due to insufficient supply of blood to the heart, leading to cardiac arrest. Thus, a person experiencing such medical condition should be treated with angioplasty procedure, which cleans the narrow and blocked blood veins. Angioplasty includes insertion of a small balloon tipped catheter into the blood vessel, which is then inflated at the site of blockage to help open the narrowed arteries.

Click To Continue Reading on Angioplasty Balloons Market

According to the health protection agency survey 2016, around 610,000 people die every year in the U.S. due to heart defects and this number is still on an upsurge. According to World Health Organizations (WHO) 2011, around 8 million individuals suffering from peripheral artery disease were recorded in the U.S. Coronary heart disease is a major cause of all the deaths in the country, which accounted for around 45% of total deaths. The prevalence of these diseases are expected to increase over the forecast period. Moreover, the growing ageing population experiencing heart ailments and diabetes, is expected to create higher demand angioplasty balloon catheters over the forecast period.

Increasing number of cardiovascular disease such as peripheral disease, coronary heart disease, and diabetes increase the global market value of angioplasty balloon. However, increase in number of key players of angioplasty balloon market has resulted in price conflicts, which is expected to curb growth of the global market.

Rise in the demand for angioplasty balloon in North America, makes it a global leader.

According to world health organizations (WHO) 2014, the North America angioplasty balloon market is predicted to reach 38% of global market share during next decade. According to the same reports, around 3.4 million people in North America are suffering from cardiovascular diseases. The growing healthcare facilities involving angioplasty in this region, have contributed to market growth. Moreover, the North American region is also a center of technological advancements and inventions of new products for catheters and angioplasty balloon, which further helps boost the market for angioplasty balloon. This makes North America a global leader of angioplasty balloon market.

According to the World Health Organizations reports (WHO) 2016, European region was the second leading global market for angioplasty balloon usage, due to the presence of large geriatric population suffering from cardiovascular diseases in the region. However, Asia Pacific region is expected to lead and emerge as the leading global user for angioplasty balloon over the forecast period. This is due to the world’s largest population present in this region with a noticeable number of people suffering from heart diseases. The costs of angioplasty balloon has decreased by around 40% in over recent decade in India, Japan, and China, which is significantly indicates growth of the angioplasty balloon market in Asia-Pacific.